Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer

Prevalence, Incidence and Predictors of Central Airway Obstruction in Patients With Advanced Lung Cancer

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01799395

Enrollment

Registered

2013-02-26

Start date

2013-02-28

Completion date

2015-03-31

Last updated

2017-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

Lung cancer may cause central airway obstruction through several different mechanisms (invasion by the primary tumor, invasion by metastatic lymph nodes, airway metastasis). The aim of the present study is to determine the prevalence at the time of diagnosis, the incidence at 1 year from the diagnosis, and the predictors of central airway obstruction associated with advanced lung cancer.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Advanced lung cancer with indication for chemotherapy or chemotherapy + radiation therapy

Exclusion criteria

* Age \< 18 year * Pregnancy * Refusal to sign informed consent

Design outcomes

Primary

Measure	Time frame	Description
Incidence of central airway obstruction	12 months	The incidence will be measured over a 12 month period after diagnosis (or over the life span from diagnosis to death in patients who die before 1 year from the diagnosis)

Secondary

Measure	Time frame	Description
Prevalence of central airway obstruction	1 day	The prevalence of central airway obstruction will be evaluated at the time of diagnosis
Predictor variables associated with the presence/occurrence of central airway obstruction	12 months	—

Countries

Italy

Outcome results